ALNY
Alnylam Pharmaceuticals, Inc.NASDAQHealthcare$318.85-3.01%ClosedMarket Cap: $42.29B
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
29
Sales
232
Buy/Sell Ratio
0.13
Total Bought
$0.00
Total Sold
$228.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Fri Mar 06 | Garg Pushkal | officer: EVP Chief R&D | Sell | 106 | $319.03 | 23,300 |
| Fri Mar 06 | Garg Pushkal | officer: EVP Chief R&D | Sell | 102 | $320.01 | 23,198 |
| Fri Mar 06 | Garg Pushkal | officer: EVP Chief R&D | Sell | 215 | $320.81 | 22,983 |
| Fri Mar 06 | Garg Pushkal | officer: EVP Chief R&D | Sell | 289 | $321.82 | 22,694 |
| Fri Mar 06 | Garg Pushkal | officer: EVP Chief R&D | Sell | 350 | $323.01 | 22,344 |
| Fri Mar 06 | Garg Pushkal | officer: EVP Chief R&D | Sell | 767 | $323.84 | 21,577 |
| Fri Mar 06 | Garg Pushkal | officer: EVP Chief R&D | Sell | 272 | $324.88 | 21,305 |
| Fri Mar 06 | Garg Pushkal | officer: EVP Chief R&D | Sell | 208 | $325.67 | 21,097 |
| Fri Mar 06 | Garg Pushkal | officer: EVP Chief R&D | Sell | 654 | $322.33 | 20,443 |
| Fri Mar 06 | Garg Pushkal | officer: EVP Chief R&D | Sell | 740 | $323.55 | 19,703 |